SCHEMBL22074336

SCHEMBL22074336

O=C(COc1ccc2c(c1)OCO2)N(c1ccccn1)C1CCSC1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 5/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.48
▸ LMNA P02545 4/20 0.48
▸ MAPT P10636 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ RAB9A P51151 6/20 0.46
▸ NPC1 O15118 5/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ PKM P14618 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20777282 0.88 TRPM8 (0.56) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL29780001 0.88 TRPM8 (0.56) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL22074335 0.88 TRPM8 (0.74) TRPM8SMN1; SMN2LMNAMAPTKMT2A
SCHEMBL22074350 0.83 TRPM8 (0.62) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL22074410 0.82 TRPM8 (0.61) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL22074438 0.82 TRPM8 (0.74) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL22074418 0.82 LMNA (0.55) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL29780004 0.82 LMNA (0.55) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL20772855 0.78 TRPM8 (0.76) TRPM8SMN1; SMN2LMNAMAPTMEN1
SCHEMBL29779963 0.78 TRPM8 (0.76) TRPM8SMN1; SMN2LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675809-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2023-09-27 — — EP disclosed
EP-3675809-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2023-09-27 — — EP disclosed
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients BASF SE (DE) 2022-09-06 — — US disclosed
EP-3675809-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-07-08 — — EP disclosed
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-06-18 — — US disclosed
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients TRPM8, TRPM7, TRPM5 TRPM8 1/4885SMN1; SMN2 4063/4885LMNA 1495/4885
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS TRPM8, TRPM7, TRPM5 TRPM8 1/4885SMN1; SMN2 4063/4885LMNA 1495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback